![Fiona Miles](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fiona Miles
Direttore/Membro del Consiglio presso Protego Medical Pty Ltd.
Provenienza dei contatti di primo grado di Fiona Miles
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Aravax Pty Ltd.
![]() Aravax Pty Ltd. BiotechnologyHealth Technology Aravax Pty Ltd. develops treatments for peanut allergies. The company was founded in May 2015 and is headquartered in Melbourne, Australia.
6
| Holding Company | Biotechnology | 6 |
Protego Medical Pty Ltd.
![]() Protego Medical Pty Ltd. Medical SpecialtiesHealth Technology Protego Medical Pty Ltd. operates as an early stage medical technology company developing a medical device for sternal protection during cardiac surgery. The firm offers Sternal Haemostasis and protection during cardiac surgery, and Sternal Protection Device (SPD). The company was founded in 2013 and is headquartered in Melbourne, Australia.
1
| Private Company | Medical Specialties | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Fiona Miles tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
SV Health Investors LLP
![]() SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
Circassia Ltd.
![]() Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Other | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Powderject Pharmaceuticals Plc
![]() Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Corporate Officer/Principal | |
BIOTA HOLDINGS LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
INNOVIVA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Immatics Biotechnologies GmbH
![]() Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
The Open University | College/University | Masters Business Admin | |
University of Giessen | College/University | Masters Business Admin | |
University of the Witwatersrand | College/University | Doctorate Degree | |
American Association of Pharmaceutical Scientists
![]() American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Biotechnology | Corporate Officer/Principal | |
Brandon Capital Partners Pty Ltd.
![]() Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Investment Managers | Private Equity Investor | |
GlaxoSmithKline LLC
![]() GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Reacta Biotech Ltd.
![]() Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Reacta Biotech Ltd. engages in a biotechnology company. It develops, manufactures, and commercializes oral food challenge materials to pharmaceuticals standards of Good Manufacturing Practice (GMP). The company was founded by Clare Mills, Ashley Woodcock, and Peter McPartland in June 2013 and is headquartered in Deeside, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
ReViral Ltd.
![]() ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Cardiora Pty Ltd.
![]() Cardiora Pty Ltd. Investment Trusts/Mutual FundsMiscellaneous Cardiora Pty Ltd. functions as a clinical stage pharmaceutical company. It develops CRD-102, an oral medicine for heart failure. The company was founded by David Kaye in 2015 and is headquartered in Melbourne, Australia. | Investment Trusts/Mutual Funds | Director/Board Member | |
Denteric Pty Ltd.
![]() Denteric Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Denteric Pty Ltd. is a biotechnology company focused on oral health. It provides developing vaccines for treating and preventing severe periodontal disease. The company was founded by Eric C. Reynolds and is headquartered in Melbourne, Australia. | Miscellaneous Commercial Services | Director/Board Member | |
IMMATICS N.V. | Biotechnology | Director of Finance/CFO | |
George Medicines UK Ltd.
![]() George Medicines UK Ltd. BiotechnologyHealth Technology George Medicines UK Ltd. is a company focused on late stage drug development to improve the management of non-communicable diseases. The company is based in London, UK. The British company does this by creating single-pill, multi-mechanism combinations of existing medicines. Stefan König has been the CEO of the company since 2021. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Regno Unito | 7 |
Stati Uniti | 7 |
Australia | 6 |
Germania | 5 |
Sud Africa | 2 |
Settori
Health Technology | 15 |
Consumer Services | 4 |
Finance | 3 |
Commercial Services | 3 |
Miscellaneous | 2 |
Posizioni
Director/Board Member | 10 |
Corporate Officer/Principal | 9 |
Chief Tech/Sci/R&D Officer | 4 |
Private Equity Investor | 2 |
Chief Executive Officer | 2 |
Contatti più connessi
Insiders | |
---|---|
Brett K. Haumann | 11 |
Pascal Hickey | 6 |
Ingmar Wahlqvist | 5 |
Thomas Ulmer | 5 |
Sara Prickett | 1 |
Chris Smith | 1 |
Judy Bingham | 1 |
- Borsa valori
- Insiders
- Fiona Miles
- Connessioni Società